Call for Proposals with
A call for proposals is being launched in the framework of
the Global Enterprise R&D Collaboration Agreement between the Office of the
Chief Scientist (OCS) of the Ministry of Economy and the
Corporation. The agreement aims
to encourage cooperation between Israeli companies and the
Corporation in the areas of
research, development and marketing.
As a multinational which has a strong corporate culture of
supporting R&D, and a presence in many sectors, this offer is directed to
companies that develop technologies and products in the following fields:
TERUMO seeks technologies which enable to seal
the femoral artery as vascular closure. The procedure should be easy to
implement and use, as well as cost effective. Specific requirements are as
- More than 14F 5mm
diameter vessel puncture site should be sealed.
- No implant material should be better. However if the implant material is
biocompatible, that would be acceptable.
- Reliable hemostasis
- Easy procedure
TERUMO seeks technologies (Materials and
Systems) which enable to cover/coat blood vessel lumen with the biocompatible
materials to treat the target lesion. The system and procedure should be easy
to implement and use, as well as cost effective. Specific technological
interests are in the following areas:
Hydrogel, Sheet, Mesh and Patch
biocompatible materials, which can adhere to blood vessel lumen and stay there under
the presence of blood flow and vasomotion.
catheter devices, which can deliver the Materials (described above) to the
target lesion and apply it to blood vessel lumen.
devices, which can apply the Materials (described above) to blood vessel lumen.
and percutaneous catheter devices are likely to exist as a combination of
Material and System, however, this is not always the case.
For more information on
Terumo Corporation and the products of Cardiac & Vascular, please visit the
corporate website at:
that are interested in applying should send a summary proposal to:
For Solution Inquiry No. 1 - to
For Solution Inquiry No. 2 - to
on all emails.
The proposals will be evaluated, on behalf of the
Office of the Chief Scientist and
.Companies whose proposals are found suitable
will be invited to meet Terumo representatives during their visit to Israel in
Furthermore, in cases that these dialogues will
generate common decisions to execute a joint R&D project with Terumo, each
Israeli partner will be able to submit a request for support within
Chief Scientist's Framework for R&D Cooperation with Multinational
Approved applications will receive the following
A Chief Scientist Grant of
up to 50% of the project's approved budget;
Additional assistance from Terumo of the same budget amount in-kind,
for support in the technological and regulatory areas; use of laboratory
equipment for R&D; sub-contractors and professional consultants; etc.
information on the Chief Scientist Framework for R&D Collaboration with
Multinational Companies is available in
and you may call Noam Bar-Gal at 03-5118116.